Search

Author/Creator Simms, M

1. Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol. (26th February 2018)

Authors:
Sydes, M R; Spears, M R; Mason, M D; Clarke, N W; Dearnaley, D P; de Bono, J S; Attard, G; Chowdhury, S; Cross, W; Gillessen, S; Malik, Z I; Jones, R; Parker, C C; Ritchie, A W S; Russell, J M; Millman, R; Matheson, D; Amos, C; Gilson, C; Birtle, A
Journal:
Annals of oncology
Issue:
Volume 29:Number 5(2018)
Page Start:
1235
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial. (27th September 2019)

Authors:
Clarke, N W; Ali, A; Ingleby, F C; Hoyle, A; Amos, C L; Attard, G; Brawley, C D; Calvert, J; Chowdhury, S; Cook, A; Cross, W; Dearnaley, D P; Douis, H; Gilbert, D; Gillessen, S; Jones, R J; Langley, R E; MacNair, A; Malik, Z; Mason, M D
Journal:
Annals of oncology
Issue:
Volume 30:Number 12(2019)
Page Start:
1992
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease. Issue 10 (3rd August 2010)

Authors:
Woods, M O; Younghusband, H B; Parfrey, P S; Gallinger, S; McLaughlin, J; Dicks, E; Stuckless, S; Pollett, A; Bapat, B; Mrkonjic, M; de la Chapelle, A; Clendenning, M; Thibodeau, S N; Simms, M; Dohey, A; Williams, P; Robb, D; Searle, C; Green, J S; Green, R C
Journal:
Gut
Issue:
Volume 59:Issue 10(2010)
Page Start:
1369
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗